An internal standard for the quantification of SM-102
Related Products
Unlabeled Version(s)
33474SM-102
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

SM-102-d4

Item No. 9004898

Technical Information
Formal Name
8-[(2-hydroxyethyl)[6-oxo-6-(undecyloxy-1,1,2,2-d4)hexyl]amino]-octanoic acid, 1-octylnonyl ester
Synonyms
  • CAY10779-d4
  • Lipid H-d4
  • LNP-102-d4
Molecular Formula
C44H83D4NO5
Formula Weight
Purity
≥98%
A 5 mg/ml solution in ethanol
Ethanol: Sparingly soluble: 1-10 mg/ml
SMILES
OCCN(CCCCCCCC(OC(CCCCCCCC)CCCCCCCC)=O)CCCCCC(OC([2H])([2H])C([2H])([2H])CCCCCCCCC)=O
InChi Code
InChI=1S/C44H87NO5/c1-4-7-10-13-16-17-18-24-32-41-49-43(47)35-29-25-31-38-45(39-40-46)37-30-23-19-22-28-36-44(48)50-42(33-26-20-14-11-8-5-2)34-27-21-15-12-9-6-3/h42,46H,4-41H2,1-3H3/i32D2,41D2
InChi Key
BGNVBNJYBVCBJH-KOHHMPBFSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Cayman Chemical
    Ionizable Lipids – Your Path from R&D to GMP

    Seamlessly bridge your LNP discovery journey from RUO to bulk GLP-tox and GMP excipient-grade material.

    Explore CGMP Lipid Services
    Product Description

    SM-102-d4 is intended for use as an internal standard for the quantification of SM-102 (Item No. 33474) by GC- or LC-MS. SM-102 is an ionizable cationic lipid (pKa = 6.68) that has been used in the generation of lipid nanoparticles (LNPs) for the delivery of mRNA and plasmid DNA in vitro and in vivo.1,2 It inhibits inward-rectifying potassium currents mediated by human-ether-a-go-go (hERG), also known as Kv11.1, in GH3 rat pituitary cells and MA-10 mouse Leydig cells (IC50s = 108 and 98 µM, respectively).3 Administration of luciferase mRNA in SM-102-containing LNPs induces hepatic luciferase expression in mice.1 LNPs containing SM-102 and Q1-SM-102 (Item No. 41239) as a cationic lipid pair (CLP) and encapsulating a luciferase reporter induce luciferase expression in the lungs and spleen in mice.4 Intramuscular immunization of LNPs containing SM-102 and encapsulating mRNA encoding the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike glycoprotein increases serum SARS-CoV-2 spike glycoprotein-specific IgG titers in mice.5 LNPs containing SM-102 and encapsulating mRNA encoding β-catenin increase bone volume in a mouse model of tibia fracture repair when administered via injection to the fracture callus.6 Formulations containing SM-102 have been used in the development of LNPs for delivery of mRNA-based vaccines.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Sabnis, S., Kumarasinghe , E.S., Salerno, T., et alA novel amino lipid series for mRNA delivery: Improved endosomal escape and sustained pharmacology and safety in non-human primates. Mol. Ther. 26(6), 1509-1519 (2018).

    2. Zhang, W., Pfeifle, A., Lansdell, C., et alThe expression kinetics and immunogenicity of lipid nanoparticles delivering plasmid DNA and mRNA in mice. Vaccines (Basel) 11(10), 1580 (2023).

    3. Cho, H.-Y., Chuang, T.-H., and Wu, S.-N. Effective perturbations on the amplitude and hysteresis of Erg-mediated potassium current caused by 1-octylnonyl 8-[(2-hydroxyethyl)[6-oxo-6(undecyloxy)hexyl]amino]-octanoate (SM-102), a cationic Lipid. Biomedicines 9(10), 1367 (2021).

    4. Zeng, G., He, Z., Yang, H., et alCationic lipid pairs enhance liver-to-lung tropism of lipid nanoparticles for in vivo mRNA delivery. ACS Appl. Mater. Interfaces 16(20), 25698-25709 (2024).

    5. Chen, K., Fan, N., Huang, H., et almRNA vaccines against SARS-CoV-2 variants delivered by lipid nanoparticles based on novel ionizable lipids. Adv. Funct. Mater. 32(39), (2022).

    6. Nelson, A.L., Mancino, C., Gao, X., et alβ-catenin mRNA encapsulated in SM-102 lipid nanoparticles enhances bone formation in a murine tibia fracture repair model. Bioact. Mater. 39, 273-286 (2024).